Higgins J R, Walshe J J, Darling M R, Norris L, Bonnar J
Rotunda Hospital, Dublin, Ireland.
Am J Obstet Gynecol. 1998 Aug;179(2):520-6. doi: 10.1016/s0002-9378(98)70389-8.
Our purpose was to determine the hemostatic changes in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.
This prospective, observational study involved 2 patient groups. Group 1 consisted of 30 normotensive women and 22 women with pre-eclampsia who were followed up longitudinally through pregnancy and post partum. Group 2 consisted of 20 women with established pre-eclampsia and 19 normotensive control subjects, all undergoing cesarean section. Plasma levels of thrombin-antithrombin III complex, soluble fibrin, plasmin-alpha2-antiplasmin complex, and fibrin-degradation product (D-dimer) were measured in blood drawn from the antecubital vein (group 1) and from both the antecubital and uterine veins (group 2). Data were analyzed by analysis of variance.
In group 1 levels of thrombin-antithrombin III complex, soluble fibrin, and fibrin-degradation product were significantly higher during normal pregnancy than at 6 weeks post partum. Plasmin-alpha2-antiplasmin complex levels did not change. No differences between the pre-eclamptic and normotensive pregnancy groups were found for any of the hemostatic markers. In group 2 normotensive women undergoing cesarean section, thrombin-antithrombin III complex and soluble fibrin levels were significantly higher in the uterine vein than in the antecubital vein. In group 2 women with pre-eclampsia, thrombin-antithrombin III complex and fibrin-degradation product levels were significantly higher in the uterine vein than in the antecubital vein. In addition, plasmin-alpha2-antiplasmin complex and fibrin-degradation product levels were higher and soluble fibrin levels were lower in the uterine vein in the pre-eclamptic group than in the normotensive group.
Both the coagulation and fibrinolytic systems are activated during normal pregnancy. Activation of these systems is more marked in the uteroplacental circulation than in the systemic circulation in both normotensive and pre-eclamptic pregnancies. An abnormal pattern of hemostasis occurs in the uteroplacental circulation in pre-eclampsia.
我们的目的是确定正常血压和先兆子痫孕妇子宫胎盘循环及外周循环中的止血变化。
这项前瞻性观察性研究涉及2个患者组。第1组由30名血压正常的女性和22名先兆子痫女性组成,在孕期及产后进行纵向随访。第2组由20名确诊为先兆子痫的女性和19名血压正常的对照受试者组成,均接受剖宫产。从肘前静脉(第1组)以及肘前静脉和子宫静脉(第2组)采集血液,测量血浆中凝血酶 - 抗凝血酶III复合物、可溶性纤维蛋白、纤溶酶 - α2 - 抗纤溶酶复合物和纤维蛋白降解产物(D - 二聚体)的水平。数据采用方差分析进行分析。
在第1组中,正常孕期凝血酶 - 抗凝血酶III复合物、可溶性纤维蛋白和纤维蛋白降解产物的水平显著高于产后6周。纤溶酶 - α2 - 抗纤溶酶复合物水平没有变化。在任何止血标志物方面,先兆子痫妊娠组和血压正常妊娠组之间均未发现差异。在第2组接受剖宫产的血压正常女性中,子宫静脉中的凝血酶 - 抗凝血酶III复合物和可溶性纤维蛋白水平显著高于肘前静脉。在第2组先兆子痫女性中,子宫静脉中的凝血酶 - 抗凝血酶III复合物和纤维蛋白降解产物水平显著高于肘前静脉。此外,先兆子痫组子宫静脉中的纤溶酶 - α2 - 抗纤溶酶复合物和纤维蛋白降解产物水平较高,可溶性纤维蛋白水平低于血压正常组。
正常孕期凝血和纤溶系统均被激活。在正常血压和先兆子痫妊娠中,这些系统的激活在子宫胎盘循环中比在体循环中更为明显。先兆子痫患者子宫胎盘循环中出现异常的止血模式。